Impact of Dairy Products on Postprandial Inflammation
The Impact of Dairy Products on Postprandial Inflammation in Obese Males
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Bern, Switzerland, 3010
- University Hospital, Inselspital Berne
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- male
- BMI ≥ 20 kg/m2
- age 25-55 y
- informed consent
Exclusion Criteria:
- Physiological or psychological diseases
- Allergies to food or intolerance to high-fat meal
- Vegetarians
- Chronic intake of drugs
- Smokers
- Diabetes mellitus Type I and II
- Debilitating kidney diseases
- Debilitating liver diseases
- Clinically established coronary heart diseases
- Ingestion of vitamins or dietary supplements during the course of the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: high fat meal without dairy products
|
|
|
Experimental: high fat meal with additional milk
|
|
|
Experimental: dairy product meal
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Inflammation markers in blood plasma (IL-6, TNF-alpha)
Time Frame: 0,6h
|
0,6h
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Biomarkers in blood (serum insulin, plasma glucose, GLP-1, lipids)
Time Frame: 0,1,2,4,6h
|
0,1,2,4,6h
|
|
Endotoxin in blood serum
Time Frame: 0,6h
|
0,6h
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Blood cell transcriptome
Time Frame: 0,2,4,6h
|
0,2,4,6h
|
|
blood serum metabolome
Time Frame: 0,2,4,6h
|
0,2,4,6h
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Kur Laederach, MD, University Hospital Inselspital, Berne
- Study Director: Alexandra Schmid, Agroscope Liebefeld-Posieux ALP
- Study Director: Caroline Buri, MD, PhD, University Hospital Inselspital, Berne
- Study Director: Guy Vergères, PhD, Agroscope Liebefeld-Posieux ALP
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- NUTRICHIP-2
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.